Document is current
Any future updates will be listed below
-
Authors
Meldau, Eva-Lisa https://orcid.org/0000-0003-0268-7769
Bista, Shachi https://orcid.org/0000-0001-8319-4936
Melgarejo-González, Carlos https://orcid.org/0009-0006-2742-1667
Norén, G. Niklas https://orcid.org/0000-0002-4595-230X
- License Information
-
More Information
Article History
Received: 27 September 2023
Accepted: 25 November 2024
First Online: 23 December 2024
Declarations
:
: This study has received ethical approval from Etikprövningsmyndigheten, the Swedish Ethical Review Authority, Uppsala, Sweden (Dnr 2019–05722). This research falls within 3 § 1 p. etikprövningslagen (special categories of personal data), the national ethical review act. The research is not of the kind outlined in 4 § etikprövningslagen, which means that consent is not required for this research. All methods were performed in accordance with relevant guidelines and regulations.
: Not applicable.
: The authors declare no competing interests.
: Uppsala Monitoring Centre is a non-profit foundation established in 1978 through an agreement between the World Health Organisation (WHO) and the Government of Sweden. It is the designated WHO Collaborating Centre for International Drug Monitoring and custodian and manager of VigiBase, the WHO global database of adverse event reports for medicines and vaccines. VigiBase brings together adverse event reports from members of the WHO Programme for International Drug Monitoring including the UK MHRA.
